ProfileGDS4718 / 222609_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 85% 86% 86% 83% 90% 91% 86% 84% 85% 85% 85% 88% 91% 90% 88% 86% 90% 92% 90% 86% 86% 85% 86% 86% 90% 84% 90% 83% 90% 91% 90% 85% 84% 89% 93% 88% 88% 87% 90% 86% 88% 89% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6273686
GSM549102patient 115, normal, homogenized [OPG study]8.3799985
GSM549104patient 119, normal, homogenized [OPG study]8.6935386
GSM549108patient 138, normal, homogenized [OPG study]8.4496486
GSM549119patient 077, normal, homogenized [OPG study]8.1324783
GSM549133patient 032, cancer, homogenized [OPG study]9.3030890
GSM549139patient 042, cancer, homogenized [OPG study]9.3567791
GSM549099patient 107, normal, homogenized [OPG study]8.5892686
GSM549109patient 139, normal, homogenized [OPG study]8.2319184
GSM549110patient 046, normal, homogenized [OPG study]8.4862885
GSM549114patient 063, normal, homogenized [OPG study]8.6021585
GSM549122patient 082, normal, homogenized [OPG study]8.43485
GSM549134patient 033, cancer, homogenized [OPG study]8.9175788
GSM549136patient 036, cancer, homogenized [OPG study]9.4184591
GSM549140patient 044, cancer, homogenized [OPG study]9.1972590
GSM549111patient 047, normal, homogenized [OPG study]8.9134588
GSM549113patient 057, normal, homogenized [OPG study]8.8100586
GSM549132patient 031, cancer, homogenized [OPG study]9.0965990
GSM549137patient 038, cancer, homogenized [OPG study]9.5138892
GSM549142patient 047, cancer, homogenized [OPG study]8.7004890
GSM549100patient 110, normal, homogenized [OPG study]8.5361886
GSM549107patient 135, normal, homogenized [OPG study]8.6732686
GSM549115patient 068, normal, homogenized [OPG study]8.6124785
GSM549116patient 072, normal, homogenized [OPG study]8.6968186
GSM549120patient 078, normal, homogenized [OPG study]8.5863486
GSM549131patient 030, cancer, homogenized [OPG study]9.2430890
GSM549118patient 074, normal, homogenized [OPG study]8.4084384
GSM549129patient 027, cancer, homogenized [OPG study]9.071990
GSM549123patient 088, normal, homogenized [OPG study]8.2731183
GSM549124patient 006, cancer, homogenized [OPG study]9.0728690
GSM549126patient 015, cancer, homogenized [OPG study]9.3322691
GSM549128patient 025, cancer, homogenized [OPG study]9.1553690
GSM549103patient 117, normal, homogenized [OPG study]8.306385
GSM549117patient 073, normal, homogenized [OPG study]8.3704684
GSM549138patient 041, cancer, homogenized [OPG study]9.1002489
GSM549141patient 045, cancer, homogenized [OPG study]9.8136293
GSM549130patient 028, cancer, homogenized [OPG study]8.8241588
GSM549101patient 111, normal, homogenized [OPG study]8.7636288
GSM549105patient 128, normal, homogenized [OPG study]8.6320287
GSM549106patient 134, normal, homogenized [OPG study]9.2774390
GSM549112patient 048, normal, homogenized [OPG study]8.6090486
GSM549125patient 011, cancer, homogenized [OPG study]8.8660488
GSM549127patient 024, cancer, homogenized [OPG study]8.9529789
GSM549135patient 035, cancer, homogenized [OPG study]9.6976292